Affiliation:
1. GR Micro Limited, London, United Kingdom
Abstract
ABSTRACT
Telithromycin MICs for 13,874
Streptococcus pneumoniae
isolates collected in the first 3 years of the global PROTEKT study (1999 to 2003) were studied. There was no change in the distribution of telithromycin MICs over this period, even in countries where telithromycin is in use. The telithromycin MICs for 10 isolates (0.07%) were ≥4 μg/ml, and these 10 isolates contained
erm
(B); there was no evidence of reproducible clonal spread between centers.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference8 articles.
1. Bozdogan, B., P. C. Appelbaum, L. M. Kelly, D. B. Hoellman, A. Tambic-Andrasevic, L. Drukalska, W. Hryniewicz, H. Hupkova, M. R. Jacobs, J. Kolman, M. Konkoly-Thege, J. Miciuleviciene, M. Pana, L. Setchanova, J. Trupl, and P. Urbaskova. 2003. Activity of telithromycin and seven other agents against 1034 pediatric Streptococcus pneumoniae isolates from ten central and eastern European centers. Clin. Microbiol. Infect.9:653-661.
2. Antipneumococcal Activity of Telithromycin by Agar Dilution, Microdilution, E Test, and Disk Diffusion Methodologies
3. Macrolide Resistance by Ribosomal Mutation in Clinical Isolates of
Streptococcus pneumoniae
from the PROTEKT 1999-2000 Study
4. Farrell, D. J., I. Morrissey, S. Bakker, and D. Felmingham. 2002. Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study. J. Antimicrob. Chemother.50(Suppl. S1):39-47.
5. Felmingham, D. 2002. The need for antimicrobial resistance surveillance. J. Antimicrob. Chemother.50:1-7.
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献